Corrigendum: Southern African guidelines on the safe, easy and effective use of pre-exposure prophylaxis: 2020

Linda-Gail Bekker¹, Benjamin Brown², Dvora Joseph-Davey^{3

4}, Kathrine Gill¹, Michelle Moorhouse⁵, Sinead Delany-Moretlwe⁵, Landon Myer⁴, Catherine Orrell^{1

6}, Kevin Rebe^{7

8}, W D Francois Venter⁹, Carole L Wallis¹⁰

Affiliations

¹ Desmond Tutu HIV Centre, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
² Anova Health Institute, Johannesburg, South Africa.
³ Department of Epidemiology, University of California, Los Angeles, United States of America.
⁴ Division of Epidemiology and Biostatistics, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.
⁵ Wits Reproductive Health and HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
⁶ Department of Medicine, University of Cape Town, Cape Town, South Africa.
⁷ Life Vincent Pallotti Hospital, Cape Town, South Africa.
⁸ Department of Medicine and Infectious Diseases, University of Cape Town, Cape Town, South Africa.
⁹ Ezintsha, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
¹⁰ BARC-SA, Speciality Molecular Division, Lancet Laboratories, Johannesburg, South Africa.

Published Erratum

Linda-Gail Bekker et al. South Afr J HIV Med. 2021.

. 2021 Dec 8:10:1295.

doi: 10.4102/sajhivmed.v22i1.1295. eCollection 2021.

¹ Desmond Tutu HIV Centre, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
² Anova Health Institute, Johannesburg, South Africa.
³ Department of Epidemiology, University of California, Los Angeles, United States of America.
⁴ Division of Epidemiology and Biostatistics, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.
⁵ Wits Reproductive Health and HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
⁶ Department of Medicine, University of Cape Town, Cape Town, South Africa.
⁷ Life Vincent Pallotti Hospital, Cape Town, South Africa.
⁸ Department of Medicine and Infectious Diseases, University of Cape Town, Cape Town, South Africa.
⁹ Ezintsha, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
¹⁰ BARC-SA, Speciality Molecular Division, Lancet Laboratories, Johannesburg, South Africa.

Abstract

[This corrects the article DOI: 10.4102/sajhivmed.v21i1.1152.].

Southern African guidelines on the safe, easy and effective use of pre-exposure prophylaxis: 2020.
Bekker LG, Brown B, Joseph-Davey D, Gill K, Moorhouse M, Delany-Moretlwe S, Myer L, Orrell C, Rebe K, Venter WDF, Wallis CL. Bekker LG, et al. South Afr J HIV Med. 2020 Dec 10;21(1):1152. doi: 10.4102/sajhivmed.v21i1.1152. eCollection 2020. South Afr J HIV Med. 2020. PMID: 33354364 Free PMC article. No abstract available.